![]() |
市場調查報告書
商品編碼
1780231
組織庫市場規模、佔有率、成長分析(按產品、組織類型、應用、最終用戶和地區)- 產業預測,2025 年至 2032 年Tissue Banking Market Size, Share, and Growth Analysis, By Product (Equipment, Cryopreservation Equipment), By Tissue Type (Heart Valves, Cornea), By Application, By End-User, By Region - Industry Forecast 2025-2032 |
2023 年全球組織庫市場規模價值 43 億美元,預計將從 2024 年的 45.3 億美元成長到 2032 年的 68.4 億美元,預測期間(2025-2032 年)的複合年成長率為 5.3%。
全球組織庫市場正經歷強勁成長,這得益於再生醫學需求的不斷成長、慢性疾病患者數量的不斷增加以及組織保存技術的不斷進步。老年人口的不斷成長和組織捐贈意識的不斷提升,對市場擴張做出了巨大貢獻。此外,政府在醫療基礎設施方面的措施和投資,正在支持世界各地現代生物庫設施的發展。北美目前憑藉其較高的採用率和良好的法律規範佔據市場主導地位,而亞太地區則在醫療支出成長和捐贈者意識提升項目的推動下,正逐漸成為一個有利的市場。
Global Tissue Banking Market size was valued at USD 4.3 Billion in 2023 poised to grow from USD 4.53 Billion in 2024 to USD 6.84 Billion by 2032, growing at a CAGR of 5.3% in the forecast period (2025-2032).
The Global Tissue Banking Market is experiencing robust growth, driven by increasing demand for regenerative medicine, rising cases of chronic diseases, and advancements in tissue preservation technologies. The expanding geriatric population and growing awareness about tissue donation are significantly contributing to market expansion. Additionally, government initiatives and investments in healthcare infrastructure are supporting the development of modern biobanking facilities worldwide. North America currently dominates the market due to high adoption rates and favorable regulatory frameworks, while Asia-Pacific is emerging as a lucrative region, fueled by rising healthcare spending and improved donor awareness programs.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tissue Banking market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Tissue Banking Market Segments Analysis
The global tissue banking market is segmented based on application, tissue bank, end use, and region. In terms of application, the market is grouped into regenerative medicine, drug discovery, tissue engineering, and transplantation. Based on the tissue bank, the market is trifurcated into cell bank, organ bank, and tissue bank. Based on end use, the market is segmented into hospitals, research institutions, and pharmaceutical companies. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Central & South America and the Middle East & Africa.
Driver of the Global Tissue Banking Market
A prominent catalyst for the expansion of the global tissue banking market is the increasing need for regenerative medicine. The growing interest in stem cell therapies, tissue transplants, and customized treatments has led to a heightened demand for essential biological materials stored in tissue banks. This surge in demand is driving advancements in tissue preservation technologies and the development of biobanking infrastructures around the world. As healthcare continues to evolve towards more innovative and personalized approaches, the role of tissue banking becomes increasingly vital, facilitating the availability of crucial resources for researchers and clinicians alike.
Restraints in the Global Tissue Banking Market
The expansion of the global tissue banking market faces significant challenges due to ethical and legal issues related to tissue donation, consent, and privacy. The presence of strict regulations and diverse laws across different regions complicates the processes of tissue collection and utilization. This complexity poses difficulties for tissue banks in implementing uniform practices, as they must navigate and comply with local ethical requirements. Consequently, these constraints can limit the availability of tissues for research and therapeutic applications, ultimately hindering the growth and development of this vital sector in healthcare. Maintaining a balance between ethical considerations and operational efficiency remains a critical concern.
Market Trends of the Global Tissue Banking Market
The global tissue banking market is experiencing a notable trend characterized by the increased adoption of automated biobanking systems. This shift towards automation enhances operational efficiency and significantly minimizes human error, resulting in higher preservation quality of biological samples. As institutions strive for innovation and streamlined processes, advanced technologies such as automated tissue collection, storage, and analysis systems are becoming integral to tissue banking operations. This trend not only boosts the reliability of sample handling but also meets the growing demand from research and clinical applications, ultimately contributing to the market's expansion and evolving landscape as stakeholders prioritize precision and efficiency in tissue preservation.